The phenotypic shift induced in melanoma cells by these double treatments is dependent on YAP1 (yes-associated protein 1)- and MRTFA (Myocardin Related Transcription Factor A)-activity in resistant melanoma cells. This evidence concerns the gene YAP1 and melanoma.